Novo Nordisk Norway AS
Postboks 4814, Nydalen
NO-0484 Oslo
Visiting address:
Nydalsveien 28
NO-0484 Oslo
Municipality: Oslo
County: Oslo
Telephone: +47 67178500
Fax: +47 67130911

Fiscal year 202212
Turnover: 1,482,659
Financial expenses: 464
Earnings before taxes: 58,984
Total assets: 699,007
Current assets: 696,138
Current liabilities: 692,887
Equity capital: 2,574
Share capital: 250

Financial ratios

Solvency: 0.4%
Profitability: 4.0%
Return on equity (ROE): 2.291.5%
Current ratio: 100.5%
Return on assets (ROA): 8.5%